Cypherpunk Technologies Inc (CYPH) Stock Price, Quote & News

Company Profile

Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an optio...

Industry: Asset Management

Sector: Financial Services

Phone: 617 714 0360

Website: www.leaptx.com

Address:

47 Thorndike Street, Suite B1-1, Cambridge, United States

RichThroughLIRA Jan. 14 at 3:01 PM

$CYPH 0.85 today

0 · Reply

RoarinKitty Jan. 14 at 3:00 PM

$CYPH THIS IS GOING TO $5. THERE IS NO DOUBT ABOUT THAT. SOONER RATHER THAN LATER.

0 · Reply

Syo23 Jan. 14 at 2:35 PM

$CYPH need volume

0 · Reply

DubLad76 Jan. 14 at 12:01 PM

$ZEC.X this needs to get exciting quickly! Let clarity be that driver. Come on, give us something to really cheer about!! $CYPH needs a rocket up its backside!

0 · Reply

DubLad76 Jan. 14 at 11:56 AM

$CYPH my head is melting waiting for something to happen. Dull as dishwater. Come in $CYPH! Give us something to cheer!

0 · Reply

michaelburryburner Jan. 14 at 3:28 AM

$CYPH give me the patience to hold, $5 will happen

0 · Reply

deano361 Jan. 14 at 2:28 AM

$CYPH $ZEC.X so now we are running with the market ?

0 · Reply

little_leaf Jan. 13 at 9:46 PM

$CYPH wtf.. btc running without me and you.

1 · Reply

RichThroughLIRA Jan. 13 at 4:11 PM

$CYPH monero will take this down to 0.85

1 · Reply

BottomFishingCharts Jan. 13 at 2:40 PM

#Bitcoin on a rip (Up 1.5k+)... $CYPH and $ZOOZ are lagging..

0 · Reply

Cypherpunk Accelerates Zcash Accumulation; Increases Treasury Holdings to 290,062.67 ZEC

Dec 19, 2025, 7:00 AM EST - 26 days ago

Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor

Dec 15, 2025, 12:59 PM EST - 4 weeks ago

Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript

Dec 9, 2025, 7:00 AM EST - 5 weeks ago

Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor

Nov 12, 2025, 8:00 AM EST - 2 months ago

Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 7:00 AM EST - 2 months ago

Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

Oct 20, 2025, 7:00 AM EDT - 3 months ago

Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025

Oct 9, 2025, 7:00 AM EDT - 3 months ago

Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

Oct 6, 2025, 9:00 AM EDT - 3 months ago

Leap Therapeutics Announces $58.88 Million Private Placement in Cash Commitments Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

Sep 25, 2025, 7:00 AM EDT - 3 months ago

Leap Therapeutics to Present Final Clinical Data from Part B of the DeFianCe Study at the ESMO Congress 2025

Aug 14, 2025, 7:00 AM EDT - 5 months ago

Leap Therapeutics Reports Second Quarter 2025 Financial Results

Jun 23, 2025, 7:00 AM EDT - 7 months ago

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

May 13, 2025, 7:00 AM EDT - 8 months ago

Leap Therapeutics Reports First Quarter 2025 Financial Results

Apr 25, 2025, 1:00 PM EDT - 9 months ago

Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 9 months ago

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer

Mar 31, 2025, 1:42 PM EDT - 10 months ago

Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript

Mar 26, 2025, 1:29 PM EDT - 10 months ago

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer

Mar 26, 2025, 7:05 AM EDT - 10 months ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 26, 2025, 7:00 AM EDT - 10 months ago

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

Jan 28, 2025, 7:00 AM EST - 1 year ago

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study

Jan 6, 2025, 7:01 AM EST - 1 year ago

Leap Therapeutics: A Buy On Near-Term Data Catalysts In Stomach And Colon Cancer

Jan 6, 2025, 7:00 AM EST - 1 year ago

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 26, 2024, 7:00 AM EST - 1 year ago

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference

Nov 13, 2024, 7:00 AM EST - 1 year ago

Leap Therapeutics Reports Third Quarter 2024 Financial Results

Sep 30, 2024, 7:00 AM EDT - 1 year ago

Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Leap Therapeutics Reports Second Quarter 2024 Financial Results

May 13, 2024, 7:00 AM EDT - 1 year ago

Leap Therapeutics Reports First Quarter 2024 Financial Results

Apr 11, 2024, 8:30 AM EDT - 1 year ago

Leap Therapeutics Announces $40 Million Private Placement

Mar 18, 2024, 7:00 AM EDT - 1 year ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Jan 16, 2024, 5:05 PM EST - 2 years ago

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

Jan 3, 2024, 7:00 AM EST - 2 years ago

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 7:00 AM EST - 2 years ago

Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients

Dec 11, 2023, 4:05 PM EST - 2 years ago

Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium

Nov 21, 2023, 7:00 AM EST - 2 years ago

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

Nov 13, 2023, 7:00 AM EST - 2 years ago

Leap Therapeutics Reports Third Quarter 2023 Financial Results

Sep 5, 2023, 7:00 AM EDT - 2 years ago

Leap Therapeutics to Participate at Upcoming Investor Conferences

Aug 14, 2023, 7:00 AM EDT - 2 years ago

Leap Therapeutics Reports Second Quarter 2023 Financial Results

Jul 12, 2023, 7:00 AM EDT - 2 years ago

Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients

Jun 20, 2023, 12:30 PM EDT - 2 years ago

Leap Therapeutics Announces Reverse Stock Split

May 25, 2023, 5:10 PM EDT - 2 years ago

Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting

May 15, 2023, 7:00 AM EDT - 2 years ago

Leap Therapeutics Reports First Quarter 2023 Financial Results

Apr 12, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients

Mar 24, 2023, 7:00 AM EDT - 3 years ago

Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 16, 2023, 4:05 PM EDT - 3 years ago

Leap Therapeutics Provides Update on BeiGene Option Agreement for DKN-01

Jan 17, 2023, 8:00 AM EST - 3 years ago

Leap Therapeutics Acquires Flame Biosciences

Jan 11, 2023, 7:00 AM EST - 3 years ago

Leap Therapeutics to Present at B. Riley Securities' 3rd Annual Oncology Conference

RichThroughLIRA Jan. 14 at 3:01 PM

$CYPH 0.85 today

0 · Reply

RoarinKitty Jan. 14 at 3:00 PM

$CYPH THIS IS GOING TO $5. THERE IS NO DOUBT ABOUT THAT. SOONER RATHER THAN LATER.

0 · Reply

Syo23 Jan. 14 at 2:35 PM

$CYPH need volume

0 · Reply

DubLad76 Jan. 14 at 12:01 PM

$ZEC.X this needs to get exciting quickly! Let clarity be that driver. Come on, give us something to really cheer about!! $CYPH needs a rocket up its backside!

0 · Reply

DubLad76 Jan. 14 at 11:56 AM

$CYPH my head is melting waiting for something to happen. Dull as dishwater. Come in $CYPH! Give us something to cheer!

0 · Reply

michaelburryburner Jan. 14 at 3:28 AM

$CYPH give me the patience to hold, $5 will happen

0 · Reply

deano361 Jan. 14 at 2:28 AM

$CYPH $ZEC.X so now we are running with the market ?

0 · Reply

little_leaf Jan. 13 at 9:46 PM

$CYPH wtf.. btc running without me and you.

1 · Reply

RichThroughLIRA Jan. 13 at 4:11 PM

$CYPH monero will take this down to 0.85

1 · Reply

BottomFishingCharts Jan. 13 at 2:40 PM

#Bitcoin on a rip (Up 1.5k+)... $CYPH and $ZOOZ are lagging..

0 · Reply

RichThroughLIRA Jan. 13 at 2:14 PM

$CYPH 0.85 coming soon

0 · Reply

deano361 Jan. 13 at 1:27 PM

$CYPH $ZEC.X section Here for any ETFs before 2026 wouid treat tokens as commodities therefore full clarity instantly. Grayscale !! Zec commodity , not security . https://x.com/cointelegraph/status/2010943215034040440?s=46&t=5ZlRqS0Wfi9BNWKligb-Qw

0 · Reply

deano361 Jan. 13 at 1:16 PM

$CYPH clarity as mentioned Months ago is coming . More reason to long crypto for 2026 imo !! Glta

0 · Reply

DubLad76 Jan. 13 at 10:41 AM

$ZEC.X nice, holding well. Is that big move up starting today? $CYPH

0 · Reply

vvvvvvrebel89130 Jan. 13 at 9:49 AM

$CYPH has to be a positive for crypto stocks UPDATE: The Senate votes Jan. 15 on the CLARITY Act, a crypto rulebook aimed at killing fake volume, wash trades, and shady reserves.

0 · Reply

deano361 Jan. 13 at 1:52 AM

$CYPH $ZEC.X wow https://x.com/dignitycipher/status/2010735646856397206?s=46&t=5ZlRqS0Wfi9BNWKligb-Qw

0 · Reply

deano361 Jan. 13 at 12:46 AM

$ZEC.X $CYPH Soon!! https://x.com/anonymist/status/2010775590274769028?s=46&t=5ZlRqS0Wfi9BNWKligb-Qw

0 · Reply

SteveStachion Jan. 13 at 12:39 AM

$CYPH would be "smart" if the VW twins expanded their holdings to multiple privacy coins + some btc/eth. Cant hurt. Price holding up better than i thought it would.

1 · Reply

RichThroughLIRA Jan. 12 at 8:23 PM

$CYPH 0.85 tomorrow

1 · Reply

michaelburryburner Jan. 12 at 6:47 PM

$CYPH chart has falling wedge all over it $2 soon

0 · Reply

Cairnsman Jan. 12 at 6:44 PM

$CYPH just because a split has been authorised doesn’t mean it will yet !

1 · Reply

Hegotgame88 Jan. 12 at 6:38 PM

$CYPH

0 · Reply

Market Cap	46.00M
Revenue (ttm)	0.00
Net Income (ttm)	-67.56M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	3,412,100
Avg Vol	30,619,592
Day's Range	N/A - N/A
Shares Out	41.44M
Stochastic %K	27%
Beta	-0.19
Analysts	Strong Buy
Price Target	N/A